Cargando…

YBX1 mediates autophagy by targeting p110β and decreasing the sensitivity to cisplatin in NSCLC

Y-box binding protein 1 (YBX1) is involved in the development of multiple types of tumors. However, the relationship between YBX1 and autophagy in non-small cell lung cancer (NSCLC) remains unclear. In this study, we analyzed the expression and clinical significance of YBX1 and markers of autophagy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Yanwei, Li, Fengzhou, Xie, Qiang, Zhao, Shilei, Guo, Tao, Guo, Ping, Hu, Sheng, Hao, Jiaojiao, Tian, Chunfang, Yu, Wendan, Li, Zhuoshi, Fang, Lei, Zhao, Lei, Chen, Manyu, Wu, Taihua, Gu, Chundong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305216/ https://www.ncbi.nlm.nih.gov/pubmed/32561752 http://dx.doi.org/10.1038/s41419-020-2555-4

Ejemplares similares

YBX1 Enhances Metastasis and Stemness by Transcriptionally Regulating MUC1 in Lung Adenocarcinoma
por: Xie, Qiang, et al.
Publicado: (2021)

YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma
por: Zhao, Shilei, et al.
Publicado: (2016)

The Nutritional Cytokine Leptin Promotes NSCLC by Activating the PI3K/AKT and MAPK/ERK Pathways in NSCLC Cells in a Paracrine Manner
por: Li, Fengzhou, et al.
Publicado: (2019)

CYP1B1 G199T Polymorphism Affects Prognosis of NSCLC Patients with the Potential to Be an Indicator and Target for Precise Drug Intervention
por: Li, Fengzhou, et al.
Publicado: (2017)

LINC00857 Interacting with YBX1 to Regulate Apoptosis and Autophagy via MET and Phosphor-AMPKa Signaling
por: Su, Wenmei, et al.
Publicado: (2020)

High expression of Y-box-binding protein 1 correlates with poor prognosis and early recurrence in patients with small invasive lung adenocarcinoma
por: Zhao, Shilei, et al.
Publicado: (2016)

New additional scoring formula on the Pathological Features in Stage I Lung Adenocarcinoma Patients: Impact on Survival
por: Zhao, Shilei, et al.
Publicado: (2020)

Comparison between functional lung volume measurement and segment counting for predicting postoperative pulmonary function after pulmonary resection in lung cancer patients
por: Fan, Zheyuan, et al.
Publicado: (2023)

Silencing of PRR11 suppresses cell proliferation and induces autophagy in NSCLC cells
por: Zhang, Lian, et al.
Publicado: (2017)

Transcriptional and post-transcriptional control of autophagy and adipogenesis by YBX1
por: Wu, Ruifan, et al.
Publicado: (2023)

Genetic Mutation Analysis in Small Cell Lung Cancer by a Novel NGS-Based Targeted Resequencing Gene Panel and Relation with Clinical Features
por: Jin, Wang, et al.
Publicado: (2021)

YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma
por: Guo, Tao, et al.
Publicado: (2017)

Correction: YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma
por: Guo, Tao, et al.
Publicado: (2023)

Importin 13 promotes NSCLC progression by mediating RFPL3 nuclear translocation and hTERT expression upregulation
por: Zohud, Bisan Abdalfatah, et al.
Publicado: (2020)

The Antitumor Efficacy of β-Elemene by Changing Tumor Inflammatory Environment and Tumor Microenvironment
por: Xie, Qiang, et al.
Publicado: (2020)

PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer
por: Yu, Wendan, et al.
Publicado: (2020)

YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia
por: Li, Huan, et al.
Publicado: (2023)

Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
por: Ma, Yuzhu, et al.
Publicado: (2019)

Phosphorylated YBX2 is stabilized to promote glycolysis in brown adipocytes
por: Zhao, Qingwen, et al.
Publicado: (2023)

The long noncoding RNA LINC00312 induces lung adenocarcinoma migration and vasculogenic mimicry through directly binding YBX1
por: Peng, Zhenzi, et al.
Publicado: (2018)

Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter
por: Jiang, Wei, et al.
Publicado: (2020)

Inhaled Cisplatin for NSCLC: Facts and Results
por: Kosmidis, Christoforos, et al.
Publicado: (2019)

SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1
por: Gao, Wujiang, et al.
Publicado: (2022)

The Pleiotropic Effects of YBX1 on HTLV-1 Transcription
por: Smith, Susan, et al.
Publicado: (2023)

Ambra1 induces autophagy and desensitizes human prostate cancer cells to cisplatin
por: Liu, Jie, et al.
Publicado: (2019)

Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification
por: Zhao, Shilei, et al.
Publicado: (2015)

MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway
por: Lin, Zhilai, et al.
Publicado: (2020)

BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits
por: Zhao, Xinrui, et al.
Publicado: (2018)

The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma
por: Niu, Jianfang, et al.
Publicado: (2022)

YBX1 promotes tumor growth by elevating glycolysis in human bladder cancer
por: Xu, Liuyu, et al.
Publicado: (2017)

Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids
por: Han, Yi, et al.
Publicado: (2022)

YBX1‐Mediated DNA Methylation‐Dependent SHANK3 Expression in PBMCs and Developing Cortical Interneurons in Schizophrenia
por: Ni, Peiyan, et al.
Publicado: (2023)

circRNA_103615 contributes to tumor progression and cisplatin resistance in NSCLC by regulating ABCB1
por: Liang, Hongguang, et al.
Publicado: (2021)

Inhibition of SMYD2 Sensitized Cisplatin to Resistant Cells in NSCLC Through Activating p53 Pathway
por: Shang, Lei, et al.
Publicado: (2019)

YBX1 Promotes the Inclusion of RUNX2 Alternative Exon 5 in Dental Pulp Stem Cells
por: Shen, Jiaoxiang, et al.
Publicado: (2021)

CLEC4M is associated with poor prognosis and promotes cisplatin resistance in NSCLC patients
por: Tan, Li-Ming, et al.
Publicado: (2019)

CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
por: Lin, Yuxiang, et al.
Publicado: (2022)

MicroRNA-22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma
por: Meng, Chen-Yang, et al.
Publicado: (2020)

Elevated nuclear YBX1 expression and the clinicopathological characteristics of patients with solid tumors: a meta-analysis
por: Zhang, Chunze, et al.
Publicado: (2019)

LncRNA SNHG1 upregulates ROCK2 to reduce cisplatin sensitivity of NSCLC cells by targeting miR-101-3p
por: Wei, Lei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jfdfqs5orhj06ee9mk6smgrtnu